Fred E Cooperrider

Array ( [id] => 6939759 [patent_doc_number] => 20050113322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Antisense modulation of inducible nitric oxide synthase expression' [patent_app_type] => utility [patent_app_number] => 10/182049 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25012 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113322.pdf [firstpage_image] =>[orig_patent_app_number] => 10182049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7050680 [patent_doc_number] => 20050186567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Antisense modulation of peroxisome proliferator-activated receptor gamma expression' [patent_app_type] => utility [patent_app_number] => 10/181176 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23411 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20050186567.pdf [firstpage_image] =>[orig_patent_app_number] => 10181176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964519 [patent_doc_number] => 06680167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-20 [patent_title] => 'Molecules of the card-related protein family and uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/748537 [patent_app_country] => US [patent_app_date] => 2000-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 31916 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680167.pdf [firstpage_image] =>[orig_patent_app_number] => 09748537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829184 [patent_doc_number] => 20020068709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Therapeutic uses of LNA-modified oligonucleotides' [patent_app_type] => new [patent_app_number] => 09/747913 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13493 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068709.pdf [firstpage_image] =>[orig_patent_app_number] => 09747913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874606 [patent_doc_number] => 20020049174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Structured antisense nucleic acid molecules' [patent_app_type] => new [patent_app_number] => 09/742675 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11212 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049174.pdf [firstpage_image] =>[orig_patent_app_number] => 09742675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196467 [patent_doc_number] => 07638324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Bcl-G polypeptides, encoding nucleic acids and methods of use' [patent_app_type] => utility [patent_app_number] => 09/738396 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21750 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638324.pdf [firstpage_image] =>[orig_patent_app_number] => 09738396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936582 [patent_doc_number] => 20020061845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Novel molecules of the card-related protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 09/728721 [patent_app_country] => US [patent_app_date] => 2000-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 54259 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 213 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061845.pdf [firstpage_image] =>[orig_patent_app_number] => 09728721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245588 [patent_doc_number] => 06677153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Antisense antibacterial method and composition' [patent_app_type] => B2 [patent_app_number] => 09/726774 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 22806 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677153.pdf [firstpage_image] =>[orig_patent_app_number] => 09726774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1374713 [patent_doc_number] => RE038028 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Molecular genetic construction of vaccine strains of pasteurellaceae' [patent_app_type] => E1 [patent_app_number] => 09/716319 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6843 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038028.pdf [firstpage_image] =>[orig_patent_app_number] => 09716319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4376152 [patent_doc_number] => 06303354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Microbial production of indigo' [patent_app_type] => 1 [patent_app_number] => 9/721259 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 12623 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303354.pdf [firstpage_image] =>[orig_patent_app_number] => 721259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380793 [patent_doc_number] => 06551826 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Antisense modulation of raidd expression' [patent_app_type] => B1 [patent_app_number] => 09/705267 [patent_app_country] => US [patent_app_date] => 2000-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29548 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/551/06551826.pdf [firstpage_image] =>[orig_patent_app_number] => 09705267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 686852 [patent_doc_number] => 07078390 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-18 [patent_title] => 'Ribozymes to growth factor originating in human platelet' [patent_app_type] => utility [patent_app_number] => 10/110274 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 7086 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/078/07078390.pdf [firstpage_image] =>[orig_patent_app_number] => 10110274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433384 [patent_doc_number] => 06340674 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides' [patent_app_type] => B1 [patent_app_number] => 09/668822 [patent_app_country] => US [patent_app_date] => 2000-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 12129 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340674.pdf [firstpage_image] =>[orig_patent_app_number] => 09668822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565116 [patent_doc_number] => 06376189 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Method for detecting expression of human skeletal muscle-specific unbiquitin-conjugated enzyme' [patent_app_type] => B1 [patent_app_number] => 09/661468 [patent_app_country] => US [patent_app_date] => 2000-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 47126 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376189.pdf [firstpage_image] =>[orig_patent_app_number] => 09661468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 906670 [patent_doc_number] => 07332270 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-02-19 [patent_title] => 'Diagnosis of disease state using mRNA profiles in peripheral leukocytes' [patent_app_type] => utility [patent_app_number] => 09/660568 [patent_app_country] => US [patent_app_date] => 2000-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 31 [patent_no_of_words] => 56919 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332270.pdf [firstpage_image] =>[orig_patent_app_number] => 09660568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1544905 [patent_doc_number] => 06444464 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Antisense modulation of E2F transcription factor 2 expression' [patent_app_type] => B1 [patent_app_number] => 09/658679 [patent_app_country] => US [patent_app_date] => 2000-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26749 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444464.pdf [firstpage_image] =>[orig_patent_app_number] => 09658679 [rel_patent_id] =>[rel_patent_doc_number] =>)